LCDActive
Hepatic (Liver) Function Panel
L33907
Effective: September 7, 2021
Updated: December 6, 2025
Policy Summary
Covered when medically necessary for abnormal panel values, history of hepatitis or hepatotoxin exposure, hematologic disturbances linked to liver disease, monitoring of potentially hepatotoxic medications, or signs/symptoms of liver disease; routine screening or annual physical testing without signs/symptoms is excluded. Key requirements: must meet this LCD and CMS medical-necessity rules, be documented per Local Coverage Article A57802, payment is limited to covered tests in a profile (capped to the amount for only covered tests), and services may be audited.
Coverage Criteria Preview
Key requirements from the full policy
"Signs and symptoms of liver disease (e."
Sign up to see full coverage criteria, indications, and limitations.